Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Nanchang UniversityNo recent work listed

Zhengming Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1078-9538; OpenAlex author ID A5109175964. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

  1. Nano-drug delivery system for pancreatic cancer: A visualization and bibliometric analysis. Co-author DOI 10.3389/fphar.2022.1025618↗
  2. LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K/AKT pathway. Last author DOI 10.1016/j.omtn.2021.08.024↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rongfa Yuan · 1 shared paper, 2022 · strength 0.17
  2. Jiefeng Zhao · 1 shared paper, 2022 · strength 0.17
  3. Fanqin Bu · 1 shared paper, 2022 · strength 0.17
  4. Chen Huan Luo · 1 shared paper, 2021 · strength 0.16
  5. Jinfeng Zhu · 1 shared paper, 2021 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.